Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
LQWD Technologies Lightning Network Infrastructure Surpasses 1 Million Global Transactions (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Medipharm Labs Corp MEDIF


Primary Symbol: T.LABS

Healthcare Cannabis
MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes,... see more

Recent & Breaking News (TSX:LABS)

MediPharm Labs Reports Third Quarter Results

PR Newswire 7 days ago

MediPharm Labs Sets Date to Report Third Quarter 2024 Financial Results

PR Newswire 10 days ago

MediPharm Labs Announces Departure of President and Co-Founder Keith Strachan

PR Newswire October 17, 2024

MediPharm Labs Announces $2.1M Debt Repayment

PR Newswire September 17, 2024

MediPharm Labs Reports Second Quarter Results Closing in on Positive Adjusted EBITDA(1) as Gross Profit Continues to Improve

PR Newswire August 14, 2024

/R E P E A T -- MediPharm Labs Sets Date to Report Second Quarter 2024 Financial Results/

PR Newswire August 13, 2024

MediPharm Labs Sets Date to Report Second Quarter 2024 Financial Results

PR Newswire August 8, 2024

MediPharm Labs Announces Voting Results From the 2024 Annual Meeting of Shareholders

PR Newswire June 26, 2024

MediPharm bolsters revenue with new medical cannabis products

Trevor Abes  June 20, 2024

MediPharm Labs Acquires Advanced Medical Cannabis Delivery Method Technology from Remidose Aerosols

PR Newswire June 20, 2024

MediPharm Labs Reports First Quarter Results

PR Newswire May 15, 2024

MediPharm Labs Sets Date to Report First Quarter 2024 Financial Results

PR Newswire May 8, 2024

MediPharm Labs Provides Conference Call Recording Details

PR Newswire March 27, 2024

MediPharm Labs Reports Fourth Quarter and Full Year Results

PR Newswire March 27, 2024

MediPharm poised to profit from German cannabis legalization

Trevor Abes  March 25, 2024

MediPharm Labs Provides Update on German Cannabis Legalization

PR Newswire March 25, 2024

MediPharm Labs Sets Date to Report Full Year and Fourth Quarter 2023 Financial Results

PR Newswire March 22, 2024

MediPharm Labs Achieves Pharmaceutical GMP Certification with Brazilian Health Authority

PR Newswire February 7, 2024

MediPharm Labs Provides Update on Board of Directors and Long Term Incentive Program

PR Newswire December 22, 2023

MediPharm Labs Reports Third Quarter Results

PR Newswire November 14, 2023